1212 / 1708
The choice must be done on what it is expected at long term
HEARING LOSS
14 - 63 % (Gr. 1-2)
5% severe (Gr 3-4
)
< 30% Gr ½ with IMRT
XEROSTOMIA
50-95% Gr 1-2
(< 50 with IMRT
)
4 - 10%
Gr 3
(<5% with IMRT
)
CAVITIES
Up to 65%
< 25% with IMRT
TRISMUS
Up to 50%
IMRT : less than 10%
NECK FIBROSIS
40-75%
IMRT : 20-40%
(gr1-2)
25-82%
RELATIVE RISK > 14
NO IMPACT OF IMRT
GROWTH and/or Brain RETARDATION
2-35%
No known impact of
IMRT